In order to understand the multi-step processes involved in the production of overt metastases, it is essential to develop methods to quantify cancer cell input into the various steps. Such data can be used to identify potentially rate-limiting stages and, when integrated, will give a more comprehensive picture of the metastatic process as a whole. The work presented here focusses on the numbers of cancer cells released from primary tumours into the circulation and subsequently arrested in the lungs. Evaluation of the biologic significance of circulating cancer cells is hindered by the relatively few attempts to systematically quantitate cancer cells in the blood in relation to tumour growth and metastasis (Liotta et al., 1974; Butler & Gullino, 1975; Schirrmacher & Waller, 1982) . Attempts to quantitatively determine the malignant potential of circulating cancer cells have been even fewer (Dobrossy & Turi, 1976; Nakadate et al., 1979) but in the present study, a sensitive bioassay has been developed to determine both the numbers and potential tumorigenicity of circulating cancer cells. The bioassay has also been applied to the quantitation of cancer cells disseminated to the lungs. Such 
Materials and methods

Tumours
The Lewis lung carcinoma (Sugiura & Stock, 1955) was routinely transplanted in C57BL/6J female mice aged 8-10 weeks (Jackson Labs., ME). Singlecell suspensions were prepared by incubation of minced tumour tissue with a solution containing 0.25% neutral protease (Type IX, Sigma, MO), 0.25% collagenase (Type IV, Sigma, MO), and 0.02% DNAase (Deoxyribonuclease I, Sigma, MO) in Hanks' balanced salt solution (HBSS) for 15 min at 37°C with stirring. Liberated tumour cells were washed twice with HBSS and filtered through 400 gauge stainless steel mesh to remove any cell clumps. The B16FIO variant of the B16 melanoma (Fidler, 1973) was maintained in tissue culture as previously described (Skipper et al., 1964 (Skipper et al., , 1965 .27 x 10-3+0.89 x 10-3 and probably the same intercept I, zero. The repression coefficients for the 3 lines were 0.96, 0.99, and 0.99 respectively. The slope, intercept, and regression coefficient for cells plus blood plus carrier were 6.14 x10-3+0.51 X 10-3, 16.6 x 10-3+ 1.98 x 10-3 and 0.99 respectively. There were no significant differences between lines calculated as above for the Lewis lung carcinoma groups shown in Table II . The pooled slopes, intercepts and regression coefficients were 1.06 x 10-2 + 0.07x 10-2, 2.12x 10-2 +0.27 x 10-2 and 0.99 respectively.
The use of survival times to estimate the number of tumorigenic cells is a common application of this bB16F1O cells were added to normal lungs and the mixture minced before injection. C0.5 ml heparinized normal mouse blood. Tables III and IV take these confidence limits into account.
The data in Table I (Liotta et al., 1974; Butler & Gullino, 1975) , experiments involving direct counting of circulating cancer cells (Glaves, 1983) also give information about the influx of malignant cells into the blood. However, the bioassay system developed in the present studies provides a measure of the biologically critical property of these disseminated cancer cells, their potential tumorigenicity.
Bioassays have been used previously to detect otherwise covert cancer cells in tissues and body fluids (Koike et al., 1964; Grazet, 1966; Donelli et al., 1969; Wexler et al., 1971) . However, in contrast to the present study, these former assays were often used to determine presence or absence of tumorigenic cells with few attempts (Dobr6ssy & Turi, 1976 Nakadate et al., 1979 to define the limits of sensitivity of the assay or to obtain precise quantification of tumour cell load throughout tumour growth. The limiting dose bioassay method used here indicates that there is an inherent inefficiency of tumour development for both cell types which is possibly a reflection of the various host defense reactions mounted by the host against bmice died immediately after injection.
Ccoalesced nodules, too numerous to count. malignant cells (Hanna, 1980; Goldfarb & Herberman, 1982) . However, by taking advantage of the growth-promoting effects of lethally irradiated cells (Revesz, 1955) , the threshold dose is reduced to 10-100 cells.
In many experimental studies of chemotherapy regimens, lymphoid tumours such as the L1210 are used because the numbers of cells surviving after treatment can be accurately quantitated from survival curves (Skipper et al., 1964 (Skipper et al., , 1965 similar to those used in the present studies. These earlier studies relied upon the fact that these tumours will grow reproducibly from doses of < 10 cells without growth-promoting manipulations. The bioasscax developed here, however, will permit examinations of the effects of reduction therapy to be extended to solid tumours since inclusion of irradiated cells reduces the limits of quantitative detection to similarly low levels.
In the present studies, systematic bioassays showed that the entry of potentially tumorigenic cells into the circulation can be an early event, sometimes occurring within 4 days of tumour inoculation. A previous report (Stackpole, 1981) has indicated that cancer cells may be accidentally disseminated during inocula-tion i-n:i.m. or -ther extravascular sites. However, the present bioassays detected no iatrogenically disseminated cells.
Although the numbers of tumorigenic cells in the circulation increased progressively during tumour growth, there were differences in the numbers of circulating tumorigenic cells released from tumours of the same age in duplicate experiments with the same tumour. These differences were associated with the growth rate of the intramuscular lesion rather than solely tumour size and it is therefore interesting to note that in vitro experiments have demonstrated that the faster their growth rate, the more easily cells may be detached from their substrates (Weiss, 1964) . There were also wide fluctuations in the numbers of melanoma and carcinoma cells in both the blood and lungs of individual mice bearing tumours growing at the same rate. Such variations were also apparent in a study of circulating mouse lymphoma cells (Schirrmacher & Waller, 1982) . It is possible that the rates at which cancer cells are released from a primary tumour could be a characteristic property of individual tumours. However, as previously suggested (Glaves, 1983) (Fidler, 1973) and 103 Lewis carcinoma cells were needed to generate at least one pulmonary lesion. Nevertheless, the maximum lung colonization potential of either tumour is not realized during spontaneous metastasis. It has been known for many years that relatively few cancer cells-of any type prod-uce overt le-sions following direct injection into the circulation and, in common with the present studies, in those investigations in which circulating cancer cells were shed spontaneously from solid tumours, either metastases did not occur (Butler & Gullino, 1975) or were orders of magnitude less than the numbers of cancer cells released from the primary lesion (Liotta et al., 1974) . This dose-response relationship has recently been described as a contribution to "metastatic inefficiency" (Weiss, 1982 ). The present study shows that this inefficiency is not related to the tumorigenic potential of cancer cells leaving the primary tumour. This emphasizes the importance of those active specific and non-specific defense processes (Weiss & Glaves, 1976; Fidler et al., 1977; Riccardi et al., 1979; Glaves, 1980) operating in the lungs which contribute to the death of as many as 98% of these two types of tumour cells within 24 h of their initial arrest (Glaves, 1983; Fidler et al., 1976 The numbers of circulating Lewis carcinoma cells quantified by bioassay were within similar ranges to those quantitated previously by direct counting techniques (Glaves, 1983) (Strauli et al., 1980) , but this role can now be quantitatively assessed directly, in vivo, during spontaneous metastasis. 
